Ruben Osnabrugge

JANS Article

Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients

November 7, 2018 | Ruben OsnabruggeSilver Contributor

The authors of this study analyzed neurological events and quality-of-life in the Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) trial. A total of 1746 patients with aortic stenosis and intermediate surgical risk were randomized...

JANS Article

Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients

November 7, 2018 | Ruben OsnabruggeSilver Contributor

The authors of this study analyzed neurological events and quality-of-life in the Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) trial. A total of 1746 patients with aortic stenosis and...

JANS Article

Predicting Quality of Life at 1 Year After Transcatheter Aortic Valve Replacement in a Real-World Population

October 14, 2018 | Ruben OsnabruggeSilver Contributor

Despite the benefit for most patients, some patients have poor outcome after transcatheter aortic valve implantation (TAVI). Currently it is hard to predict which patient is predisposed to poor outcome...

JANS Article

Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy

October 12, 2018 | Ruben OsnabruggeSilver Contributor

The authors of this paper investigated the efficacy and safety of percutaneous intramyocardial septal radiofrequency ablation (PIMSRA) in 15 patients with hypertophic cardiomyopathy (HOCM). At six months, they found significant...

JANS Article

Radial-Artery or Saphenous-Vein Grafts in Coronary-Artery Bypass Surgery

May 1, 2018 | Ruben OsnabruggeSilver Contributor

The authors performed a patient-level meta-analysis of six randomized trials comparing left internal mammary artery (LIMA) + saphenous vein graft (SVG) versus LIMA + radial artery graft. In a total...

JANS Article

Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

July 18, 2017 | Ruben OsnabruggeSilver Contributor

In this study, the Dabigatran reversal-drug Idarucizumab was tested. 503 patients were enrolled, of whom 202 had to undergo an urgent procedure. Of the patients requiring an urgent procedure, the...

JANS Article

Aortic Valve Replacement in Younger Patients

July 15, 2017 | Ruben OsnabruggeSilver Contributor

In this editorial, the authors review the current risks associated with aortic valve replacement in younger patients, with an emphasis on anticoagulation options and future perspectives.

...
JANS Article

Fractional Flow Reserve to Guide and to Assess Coronary Artery Bypass Grafting

July 5, 2017 | Ruben OsnabruggeSilver Contributor

In this excellent review article, the authors review the practice and evidence for fractional flow reserve (FFR) in patients undergoing CABG.

...
JANS Article

CABG at 50 (or 107?) — The Complex Course of Therapeutic Innovation

May 11, 2017 | Ruben OsnabruggeSilver Contributor

With the 50th birthday of CABG, the New England Journal of Medicine published this nice article on the history and development of CABG.

...
JANS Article

Valve-in-valve outcome: design impact of a pre-existing bioprosthesis on the hydrodynamics of an Edwards Sapien XT valve

November 23, 2016 | Ruben OsnabruggeSilver Contributor

Valve in valve transcatheter aortic valve implantation (ViV-TAVI) is an alternative to redo surgical aortic valve replacement (SAVR) in inoperable patients and inpatients at high operative risk. This has become...

Video

2016 EACTS Annual Meeting Overview

October 2, 2016 | A. Pieter Kappetein…

Ruben Osnabrugge interviews EACTS Secretary General and CTSNet President Pieter Kappetein about the highlights of the 2016 EACTS Annual Meeting.

...
JANS Article

Transcatheter Aortic Valve Replacement Using Transaortic Access

September 7, 2016 | Ruben OsnabruggeSilver Contributor

This multistudy registry, entitled ROUTE, studied the effectiveness and safety of transaortic access for TAVI in 301 patients. Mean age was 82 years and mean STS Score 9.0. Valve success...

JANS Article

The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial.

August 30, 2016 | Ruben OsnabruggeSilver Contributor

The authors of this study aimed to examine the safety and efficacy of adding ezetimibe to statin in patients with prior CABG following hospitalization for an acute coronary syndrome (ACS)....

LOAD MORE
ADVERTISE ON CTSNET